As well as testing of people who meet the criteria for being at risk, the NHS and PHE are also carrying out surveillance testing on people in wards and surgeries showing signs of the virus.
Read More
The hopeful drug in question is Gilead’s investigational broad-spectrum antiviral treatment that was previously tested in humans with Ebola virus.
Read More
Of the 60 products in development, very few seem to show benefit over existing treatments.
Read More
The UK has lost its ‘measles-free’ status with WHO, just three years after the virus was eliminated in the country.
Read More
